BIOMAT Database Logo BIOMAT Database Logo

THE PROLONGED USE OF ALPHA METHYLDOPA IN THE TREATMENT OF HYPERTENSION. 1964

J RAFTOS, and D G JULIAN, and P A VALENTINE

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008750 Methyldopa An alpha-2 adrenergic agonist that has both central and peripheral nervous system effects. Its primary clinical use is as an antihypertensive agent. Methyldopate,alpha-Methyldopa,Aldomet,Alphamethyldopa,Apo-Methyldopa,Dopamet,Dopegit,Dopegyt,Dopergit,Hydopa,Meldopa,Nu-Medopa,Sembrina,alpha-Methyl-L-Dopa,Apo Methyldopa,Nu Medopa,alpha Methyl L Dopa,alpha Methyldopa
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive
D014116 Toxicology The science concerned with the detection, chemical composition, and biological action of toxic substances or poisons and the treatment and prevention of toxic manifestations. Toxinology,Evidence Based Toxicology,Evidence-Based Toxicology,Based Toxicologies, Evidence,Based Toxicology, Evidence,Evidence Based Toxicologies,Evidence-Based Toxicologies,Toxicologies, Evidence Based,Toxicologies, Evidence-Based,Toxicology, Evidence Based,Toxicology, Evidence-Based

Related Publications

J RAFTOS, and D G JULIAN, and P A VALENTINE
[Use of alpha-methyldopa in the treatment of arterial hypertension].
August 1975, La Clinica terapeutica,
J RAFTOS, and D G JULIAN, and P A VALENTINE
The combined use of L-alpha-methyldopa hydrazine and methyldopa in the treatment of hypertension.
January 1978, Clinical and experimental pharmacology & physiology. Supplement,
J RAFTOS, and D G JULIAN, and P A VALENTINE
ALPHA-METHYLDOPA IN THE TREATMENT OF HYPERTENSION.
March 1964, The Medical clinics of North America,
J RAFTOS, and D G JULIAN, and P A VALENTINE
Prolonged use of methyldopa in severe hypertension in pregnancy.
January 1966, British medical journal,
J RAFTOS, and D G JULIAN, and P A VALENTINE
[TREATMENT OF HYPERTENSION WITH ALPHA-METHYLDOPA].
September 1964, Orvosi hetilap,
J RAFTOS, and D G JULIAN, and P A VALENTINE
[ALDOMET (ALPHA-METHYLDOPA) IN THE TREATMENT OF HYPERTENSION].
January 1964, Postepy higieny i medycyny doswiadczalnej,
J RAFTOS, and D G JULIAN, and P A VALENTINE
[ALPHA-METHYLDOPA IN TREATMENT OF ARTERIAL HYPERTENSION].
February 1965, Minerva medica,
J RAFTOS, and D G JULIAN, and P A VALENTINE
[Treatment of arterial hypertension with alpha-methyldopa].
September 1969, Medicina interna,
J RAFTOS, and D G JULIAN, and P A VALENTINE
[The combined use of alpha-methyldopa and butizide in the treatment of arterial hypertension].
May 1981, La Clinica terapeutica,
J RAFTOS, and D G JULIAN, and P A VALENTINE
Alpha-methyldopa in hypertension.
July 1963, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
Copied contents to your clipboard!